Secondary per-protocol analysis: cumulative prevalence of worries during follow-up, by management received*
| Type of worry | Cumulative prevalence | |
|---|---|---|
| n | % | |
| Cervical cancer | ||
| Colposcopy & punch biopsies only | 134 | 49.1 |
| Colposcopy & immediate loop excision only | 121 | 43.1 |
| Colposcopy, punch biopsies & treatment | 47 | 54.7 |
| χ2 (2df)=4.24; p=0.120 | ||
| Sex | ||
| Colposcopy & punch biopsies only | 88 | 32.4 |
| Colposcopy & immediate loop excision only | 81 | 28.9 |
| Colposcopy, punch biopsies & treatment | 33 | 38.4 |
| χ2 (2df)=2.82; p=0.245 | ||
| Future fertility—all women | ||
| Colposcopy & punch biopsies only | 70 | 25.8 |
| Colposcopy & immediate loop excision only | 93 | 33.2 |
| Colposcopy, punch biopsies & treatment | 41 | 47.7 |
| χ2 (2df)=14.63; p=0.001 | ||
| Future fertility—restricted to women planning to have a child in the future | ||
| Colposcopy & punch biopsies only | 70 | 60.3 |
| Colposcopy & immediate loop excision only | 93 | 62.4 |
| Colposcopy, punch biopsies & treatment | 41 | 69.5 |
| χ2 (2df)=1.44; p=0.487 | ||
| General health | ||
| Colposcopy & punch biopsies only | 155 | 56.6 |
| Colposcopy & immediate loop excision only | 180 | 64.5 |
| Colposcopy, punch biopsies & treatment | 59 | 68.6 |
| χ2 (2df)=5.72; p=0.057 | ||
*Includes women whose transformation zone at colposcopy was abnormal and who, because of this, underwent additional management procedures.